To use all functions, please enable javascript. SUN PHARMA JAPAN LIMITED Company Profile - Dun & Bradstreet Sun Pharma Japan Ltd is a company that operates in the Pharmaceuticals industry. The company is headquartered in Tokyo, Kanto, Japan. While other Indian pharmaceutical companies were working primarily on antibiotics, glutamine and cough syrups, the founder of SPIL, Dilip Shanghvi, decided to strategically enter the market for lifestyle pharmaceuticals the medicine for chronic diseases, including anti-depressants and the drugs for schizophrenia and cardiovascular high blood pressure. Read More. Supported by more than 40 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe. Sun Pharma Japan Limited was established in Japan. Use our commercial database of more than 120 million business records & industry directory for company research & industry analysis. Sun Pharma to acquire Japan's Pola Pharma for $1 million Popular Searches Sun Pharmaceutical Industries Ltd Sun Pharmaceutical Industries Inc Ranbaxy Laboratories Ltd Sun Pharma Sun Pharma Industries However, there seem to be formidable obstacles to overcome when Indian companies conduct business in Japan. Shinshin Pharmaceutical Co . Sun Pharmaceutical Industries Limited has announced the sale of Kayaku Co. Ltd, a wholly-owned subsidiary of Sun Pharma Japan Limited, a step-down subsidiary of the company. [4] From humble beginnings in 1983, Sun Pharma has grown to become one of the largest generic pharmaceutical companies worldwide. Sun Pharma Japan Limited. Intellectual Property (IP) Infectious Diseases. A growing number of foreign companies have decided to start up a business in Japan drawn by the allure of the recent boom in generic drugs. you can get e-magazine links on WhatsApp. PDF Success StoriesBiotechnology/LifeScience Sun Pharma Japan Limited Mr. Muramatsu says, Doctors and pharmacists in Japan, who constitute our customers, do not even know the name of SP Japan. 402 Employees. Universal Health Coverage. Contact Us | Sun Pharma Japan Limited Please feel free to contact us via the form below for any inquiries. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Sun Pharmaceutical Industries Limited 1983 5 [2] 40 2014264 [1] Sunology, a combination of Sun and Ideology is the way of life at Sun Pharma. Sun Pharma has made nearly 20 acquisitions since . Being the worlds third largest pharmaceutical market following the US and China, Japan is seen as a country brimming with business opportunities in the life science industry, including medical equipment and the healthcare services. If they succeed in developing a highly innovative product in Japan, they will be able to promote it in other countries, too. Sun Pharma is the world's 4th largest generic pharmaceutical company and No. PDF Current Assets 11,752,681,474 Current Liabilities 7,401,232,950 This site is intended for healthcare professionals only, Sun Pharma Japan sells its subsidiary to Shinshin Pharma for Rs 24 crore, CDSCO (Central Drugs Standard Control Organisation) News. Pharma Japan"), a step-down subsidiary of the Company. 0 Product Sales Cost of Sales Gross Profit Income Statements Sun Pharma Japan Ltd. From April 1, 2022 To March 31, 2023 Selling, General and Administrative Expenses Operating Profit Non-Operating Income (JPY) 15,990,240,249 10,481,652,051 5,508,588,198 6,726,091,868 (1,217,503,670) Special Gain/Loss Special Gain Profit before Income Tax . Thus Kayaku Co. Ltd has ceased to be the subsidiary of the Company. View Company Info for Free We focused on understanding the system of the local organizations and their culture, and tried to operate those bases as a local business. To make matters worse, they have an unfavorable impression of India partly because of several Indian companies in the past which failed to capitalize on business opportunities and withdrew from the Japanese market. Home - Sun Pharmaceutical Industries Ltd. Member Companies | About Us | Japan Pharmaceutical Manufacturers The Japanese government has recently been promoting the use of generic drugs to reduce medical expenditure, which has been increasing year-by-year due to Japans aging population. You can contact us at one of our local offices near you for consultation. It is mandatory to procure user consent prior to running these cookies on your website. SUN PHARMA JAPAN LIMITED Company Profile | MINATO-KU, TOKYO, Japan | Competitors, Financials & Contacts - Dun & Bradstreet HOME / BUSINESS DIRECTORY / WHOLESALE TRADE / MERCHANT WHOLESALERS, NONDURABLE GOODS / DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS / JAPAN / TOKYO / MINATO-KU / SUN PHARMA JAPAN LIMITED SUN PHARMA JAPAN LIMITED Sun Pharmaceutical Industries Limited announced the successful completion of its acquisition of Concert Pharmaceuticals, Inc. on March 6, 2023. . Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. Succeeded manufacturing and marketing authorization for Gemcitabine from Taiho Pharmaceutical . It is engaged in the business of manufacturing pharmaceutical products for external pharmaceutical companies. It employs 251-500 people and has $25M-$50M of revenue. sun pharma api list - vdocuments.net Countermeasures against Counterfeit Medicines, International Affairs Committee(Asia Committee), Deliverables of Drug Evaluation Committee, JPMA Statement on WTO TRIPS Intellectual Property Waiver, UN Climate Change Conference (COP26): Biopharmaceutical Industry Actions to Tackle Climate Change, Three priorities to urgently increase access to COVID-19 vaccines, Statement by JPMA President on the Passing of Former Prime Minister ABE Shinzo, Opinion on Access and Benefit Sharing of Digital Sequence Information, ICH Guideline/Implementation Guide related materials (Translation into English/Japanese), Asia Partnership Conference of Pharmaceutical Associations(APAC). The Sun Story. Amendments, Govt Recognised In-House R&D
8-9-5. But opting out of some of these cookies may affect your browsing experience. Contact Us If you wish to receive specific information about Sun Pharma, please fill out the following form ( indicates required fields ). August 26, 2021 | Mumbai Detailed Rationale CRISIL Ratings has reaffirmed its 'CRISIL AAA/Stable/CRISIL A1+' ratings on the bank facilities and commercial paper programme of Sun Pharmaceutical Industries Limited (Sun Pharma). Rating Rationale - CRISIL Another decisive factor in SPILs decision to come to Japan is the Japanese governments promotion of the use of generic drugs.. Sun Pharma Italia SRL Sun Pharma Japan Ltd. Sun Pharma Japan Technical Operations Limited. 105-0011. Business Directory - Dun & Bradstreet SUN PHARMA JAPAN LIMITED Company Profile | FUJISAWA, KANAGAWA, Japan | Competitors, Financials & Contacts - Dun & Bradstreet HOME / BUSINESS DIRECTORY / WHOLESALE TRADE / MERCHANT WHOLESALERS, NONDURABLE GOODS / DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS / JAPAN / KANAGAWA / FUJISAWA / SUN PHARMA JAPAN LIMITED SUN PHARMA JAPAN LIMITED The former Saitama factory of Kayaku Company Limited newly started operation as Sun Pharma Japan Technical Operations Limited. Shinshin Pharmaceutical is a Japan-based pharmaceutical company with its office at 324 lmaich, Toyama City, Toyama 930-2224 Japan. The former Saitama factory of Kayaku Company Limited newly started operation as Sun Pharma Japan Technical Operations Limited. Sun Pharmaceutical Industries Limited | Mumbai - Facebook . | Sun Pharma Japan Limited Start sales research here. SPILIndias largest pharmaceutical company headquartered in Mumbai, Indiais one such company. Products - Sun Pharmaceutical Industries Ltd. A shorter period of time required for the development of generic drugs enables costs to remain low. SUN PHARMA JAPAN LIMITED Company Profile | FUJISAWA, KANAGAWA, Japan We are present across all major markets in Western Europe, Canada, Australia, New Zealand, Japan and China among others. It includes generics, branded generics, specialty, complex or difficult to make technology-intensive products, over-the-counter (OTC), antiretrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and Intermediates. 02 CEFPODOXIME PROXETIL (1)USDMF, CEP/COS, JDMF, 04 Clarithromycin (1)USDMF, CEP/COS, JDMF, EU WC, 05 FLUVOXAMINE MALEATE (1)USDMF, JDMF, EU WC, 06 GEMCITABINE HYDROCHLORIDE (1)USDMF, CEP/COS, JDMF, EU WC, 09 Meropenem hydrate (1)USDMF, CEP/COS, JDMF, EU WC, 10 Mesalazine (production only) (1)USDMF, CEP/COS, JDMF, EU WC, 11 Midazolam (1)USDMF, CEP/COS, JDMF, EU WC, 12 Octreotide Acetate (1)USDMF, JDMF, EU WC, 13 Ofloxacin (1)USDMF, CEP/COS, JDMF, EU WC, 14 Rabeprazole sodium (1)USDMF, JDMF, EU WC, 15 Tramadol Hydrochloride (1)USDMF, CEP/COS, JDMF, EU WC, 03 SUN PHARMACEUTICAL INDUSTRIES LIMITED. FORECASTWEST. PDF Sun Pharmaceutical Industries Ltd. - NSE India Sun Pharma Announces the Launch of ILUMYA - IndiaMedToday Continues to manufacture Lulicon and other Sun Pharma topical products. The products SPIL manufactures encompass various types of drugs ranging from tablets, capsules, and injections to innovative drugs such as percutaneous patches. This category only includes cookies that ensures basic functionalities and security features of the website. Japan External Trade Organization(JETRO). Mr. Isao Muramatsu, Chairman of the Board of Directors SP Japan (left) and Mr. Kirti, Executive Vice President of SPIL (right), Sun Pharmaceutical Industries Limited established in Vadodara, India, Sun Pharma Japan Limited established in Tokyo, Manufacture, import and distribution of pharmaceuticals and their ingredients, Cross Place Hamamatsucho, 1-7-6, Shibakoen, Minato-ku, Tokyo 105-0011. Title: duac_e_20191204indd.indd Created Date: Sun Pharmaceutical Industries Ltd: Profile, Pharma Products - IBEF Sun Pharma Japan Limited: Head Office: FORECAST Gotanda WEST 8-9-5 Nishigotanda, Shinagawa-ku, Tokyo Japan 141-0001: Registered Office: KDX Hamamatsucho Place 1-7-6 Shibakoen, Minato-ku Tokyo Japan 105-0011: Established: March 1, 2012: Business: Manufacturing, imports, and sales of pharmaceutical products and intermediates/APIs: Investors - Annual Reports of Subsidiary Companies | Sun Pharmaceutical Our broad portfolio of more than 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. SPIL owns three R&D bases in India and one in the US, putting its effort into the development of generic drugs and the innovative pharmaceuticals. In addition to generic drugs, the company is also working hard on research and development of medicines for meeting the unmet needs in patient welfare. Our E-mail newsletter introduces the latest investment environment information and the trends of foreign companies supported by JETRO. These results are derived from various public and private data sources. The first among Indian pharmaceutical companies to realise and embrace the importance of investing in research, we invest up to 7-8% of our global revenues into Research and Development (R&D) every year. Using this experience, we have acquired 16 companies in India, the US and Europe. SPIL made its way into Europe in 2007 and joined the Japanese market in 2012.